EXACT Sciences Board of Directors Rejects Acquisition Proposal from Sequenom, Inc.

MARLBOROUGH, Mass.–EXACT Sciences Corporation (NASDAQ: EXAS) announced that its Board of Directors has unanimously rejected an acquisition proposal by Sequenom, Inc. (NASDAQ: SQNM) to acquire EXACT for $1.50 per share in Sequenom common stock, subject to a collar.

The Board, after reviewing the proposal with its financial and legal advisors, has determined to reject the proposal. The Company is actively pursuing a strategic alternative that the Board believes can provide greater value to EXACT and its shareholders than the Sequenom proposal.

< | >